Rezolute to participate in btig's 3rd annual ophthalmology day

Redwood city, calif., nov. 17, 2023 (globe newswire) -- rezolute, inc. (nasdaq: rzlt), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced that the management team will participate in btig's 3rd annual ophthalmology day, taking place virtually on november 27th.
RZLT Ratings Summary
RZLT Quant Ranking